Skip to main content
https://www.highperformancecpmgate.com/rgeesizw1?key=a9d7b2ab045c91688419e8e18a006621

Illumina’s accelerator has an impressive 93 percent follow-on funding rate — here’re its latest picks

Since its launch in 1998 Illumina and its genetic analysis toolkits and services have become an essential component of the new biological manufacturing and therapeutic development industries which have emerged in the last twenty five years.

And for the past six years the company has attempted to encourage the development of the industry through an incubator program that launches new startups in the field into the market.

Since its inaugural cohort in 2014, around 93 percent of its graduates have gone on to raise additional capital. As an example, investors have poured over $150 million into Encoded Therapeutics, a provider of targeted gene therapies.

Earlier this week, the company announced its latest cohort of startups that will work with its London and San Francisco-based teams.

They include:

  • AarogyaAI Innovations Pvt. LTD, a diagnostics company whose technology quickly diagnoses drug-resistance.
  • MEDIC Life Sciences Inc., which is developing a pre-clinical testbed of millions of tumor samples based on CRISPR and cancer organoids to enable personalized targeted therapies for cancer.
  • Pluton Biosciences, LLC, a developer of herbicides and pesticides derived from bacteria, fungi, and viruses looking to replace chemical treatments.
  • WellSIM Biomedical Technologies, Inc., a tools company developing a high-throughput microfluidics-based automated processor to isolate and analyze exosomes.
  • Alchemab Therapeutics LTD, a developer of antibody therapeutics using patient antibodies.
  • Neurolytic Healthcare LTD, a diagnostics company providing genomics-driven diagnostics and personalized treatment recommendations for neurological conditions.
  • Tailor Bio LTD, a cancer diagnostics company developing a precision oncology platform to identify patterns in the genetics of tumors to predict how patients will respond to different therapies.

“As we navigate the current global pandemic, there is an even stronger urgency to create breakthrough genomics startups that will transform human health and beyond,” said Amanda Cashin, Co-founder and Global Head of Illumina Accelerator, in a statement. “By opening our second location and partnering with seed stage capital investors, we are proud to invest in these transformative startups to push the boundaries of where genomics can go.”

The accelerator program has partnered with First In Ventures, an investment organization backed in part by the family office DBM Invest, in both the US and the UK. Wing Venture Capital will also continue to provide convertible notes in the US while government entities through the Cambridgeshire & Peterborough Combined Authority will support companies in the UK.

Illumina has also opened up applications for its next batch of companies. 

Comments

Popular posts from this blog

Uber co-founder Garrett Camp steps back from board director role

Uber co-founder Garrett Camp is relinquishing his role as a board director and switching to board observer — where he says he’ll focus on product strategy for the ride hailing giant. Camp made the announcement in a short Medium post in which he writes of his decade at Uber: “I’ve learned a lot, and realized that I’m most helpful when focused on product strategy & design, and this is where I’d like to focus going forward.” “I will continue to work with Dara [Khosrowshahi, Uber CEO] and the product and technology leadership teams to brainstorm new ideas, iterate on plans and designs, and continue to innovate at scale,” he adds. “We have a strong and diverse team in place, and I’m confident everyone will navigate well during these turbulent times.” The Canadian billionaire entrepreneur signs off by saying he’s looking forward to helping Uber “brainstorm the next big idea”. Camp hasn’t been short of ideas over his career in tech. He’s the co-founder of the web 2.0 recommendatio...

Drone crash near kids leads Swiss Post and Matternet to suspend autonomous deliveries

A serious crash by a delivery drone in Switzerland have grounded the fleet and put a partnership on ice. Within a stone’s throw of a school, the incident raised grim possibilities for the possibilities of catastrophic failure of payload-bearing autonomous aerial vehicles. The drones were operated by Matternet as part of a partnership with the Swiss Post (i.e. the postal service), which was using the craft to dispatch lab samples from one medical center for priority cases. As far as potential applications of drone delivery, it’s a home run — but twice now the craft have crashed, first with a soft landing and the second time a very hard one. The first incident, in January, was the result of a GPS hardware error; the drone entered a planned failback state and deployed its emergency parachute, falling slowly to the ground. Measures were taken to improve the GPS systems. The second failure in May, however, led to the drone attempting to deploy its parachute again, only to sever the line...

How the world’s largest cannabis dispensary avoids social media restrictions

Planet 13 is the world’s largest cannabis dispensary. Located in Las Vegas, blocks off the Strip, the facility is the size of a small Walmart. By design, it’s hard to miss. Planet 13 is upending the dispensary model. It’s big, loud and visitors are encouraged to photograph everything. As part of the cannabis industry, Planet 13 is heavily restricted on the type of content it can publish on Instagram, Facebook and other social media platforms. It’s not allowed to post pictures of buds or vapes on some sites. It can’t talk about pricing or product selection on others.   View this post on Instagram   A post shared by Morgan Celeste SF Blogger (@bayareabeautyblogger) on Jan 25, 2020 at 7:54pm PST Instead, Planet 13 encourages its thousands of visitors to take photos and videos. Starting with the entrance, the facility is full of surprises tailored for the ‘gram. As a business, Planet 13’s social media content is heavily restricted a...